Need help?
    FAQ
    1. Home
    2. Businesses for Sale
    3. USA
    4. Generic Pharmaceuticals

    Generic Pharmaceuticals Businesses for Sale and Investment in USA

    Showing 1 - 2 of 2 Generic Pharmaceuticals Businesses for Sale and Investment in USA. Buy or Invest in a Generic Pharmaceutical Business. Listed by Direct Business Owners & Business Brokers.
    Filters

    • Generic Pharmaceuticals

    • USA

     

    Generic Pharmaceuticals Company Investment Opportunity in Simi Valley, USA

    Company specializing in developing innovative headache remedies, seeking investment for expansion of distribution channels.
    The company has developed remedies for headache, hangover, and migraine, positioning itself as an innovator in the market. - Manufactured and sold under its own brand name. - Currently, in the "soft" launch phase in 100 locations nationwide, the company is selling through a distribution network to pharma retail outlets such as CVS and Walmart. - The business is experiencing a high level of satisfaction and repeat buyers, indicating a strong market response to its products. - With established relationships and a sales team, the company aims to expand to hundreds of thousands of locations nationally, with a focus on e-commerce due to high margins and a product that aligns well with the subscription model for consistent repeat sales. - With over 16 years of experience in the pharma industry, the company has expertise in running a successful subscription business model, positioning it for long-term success. - The product is registered as a dietary supplement under the FDA. - There are 11 permanent employees who are necessary for running the business operations, employed in production, admin, management, sales & marketing sectors.
    Company specializing in developing innovative headache remedies, seeking investment for expansion of distribution channels.
    7.6   Simi Valley
    Run Rate Sales
    USD 12 thousand
    EBITDA Margin
    40 %
    Partial Stake Sale
    USD 500 K for 15%
    Contact Business

    Generic Pharmaceuticals Company Investment Opportunity in New York City, USA

    Generic complex injectable pharmaceutical manufacturer with 5 drugs pending approval and proven track record.
    The two main partners sold their stake in a previous company almost 10 years back and have now created their own new company. - They hold over 40 patents and are on the verge of their first approved generic complex injectable drug in a couple of months. - The facility was inspected very recently by the FDA and passed. - We have 5 drugs pending approval with a total market value of over USD 4B and only a few competitors. - The company should be worth USD 2B in another 3 years. - The business has not generated any revenue because we have been in the process of R&D in developing these drugs for the past 6 years and have invested over USD 40 million in the business.
    Generic complex injectable pharmaceutical manufacturer with 5 drugs pending approval and proven track record.
    6.8   New York City
    Run Rate Sales
    Nil
    EBITDA Margin
    Nil
    Partial Stake Sale
    USD 20 Mn for 5%
    Contact Business
    List your business on SMERGERS.
    Get visibility from 110,000+ member network of Businesses, Investors, Acquirers, Lenders and Advisors from 900+ Industries and 170+ Countries
    Create Business Profile

    Generic Pharmaceuticals Company Investment Opportunity in New York City, USA

    Generic complex injectable pharmaceutical manufacturer with 5 drugs pending approval and proven track record.
    The two main partners sold their stake in a previous company almost 10 years back and have now created their own new company. - They hold over 40 patents and are on the verge of their first approved generic complex injectable drug in a couple of months. - The facility was inspected very recently by the FDA and passed. - We have 5 drugs pending approval with a total market value of over USD 4B and only a few competitors. - The company should be worth USD 2B in another 3 years. - The business has not generated any revenue because we have been in the process of R&D in developing these drugs for the past 6 years and have invested over USD 40 million in the business.
    Generic complex injectable pharmaceutical manufacturer with 5 drugs pending approval and proven track record.
    6.8   New York City
    Run Rate Sales
    Nil
    EBITDA Margin
    Nil
    Partial Stake Sale
    USD 20 Mn for 5%
    Contact Business

    Browse Businesses by Location

    Businesses for Sale in Alabama
    Businesses for Sale in Alaska
    Businesses for Sale in Arizona
    Businesses for Sale in Arkansas
    Businesses for Sale in California
    Businesses for Sale in Colorado
    Businesses for Sale in Connecticut
    Businesses for Sale in Delaware
    Businesses for Sale in District Of Columbia
    Businesses for Sale in Florida
    Businesses for Sale in Georgia, USA
    Businesses for Sale in Hawaii
    Businesses for Sale in Idaho
    Businesses for Sale in Illinois
    Businesses for Sale in Indiana
    Businesses for Sale in Iowa
    Businesses for Sale in Kansas
    Businesses for Sale in Kentucky
    Businesses for Sale in Louisiana
    Businesses for Sale in Maine
    Businesses for Sale in Maryland
    Businesses for Sale in Massachusetts
    Businesses for Sale in Michigan
    Businesses for Sale in Minnesota
    Businesses for Sale in Mississippi
    Businesses for Sale in Missouri
    Businesses for Sale in Montana
    Businesses for Sale in Nebraska
    Businesses for Sale in Nevada
    Businesses for Sale in New Hampshire
    Businesses for Sale in New Jersey
    Businesses for Sale in New Mexico
    Businesses for Sale in New York
    Businesses for Sale in North Carolina
    Businesses for Sale in Ohio
    Businesses for Sale in Oklahoma
    Businesses for Sale in Oregon
    Businesses for Sale in Pennsylvania
    Businesses for Sale in Rhode Island
    Businesses for Sale in South Carolina
    Businesses for Sale in South Dakota
    Businesses for Sale in Tennessee
    Businesses for Sale in Texas
    Businesses for Sale in Utah
    Businesses for Sale in Vermont
    Businesses for Sale in Virginia
    Businesses for Sale in Washington
    Businesses for Sale in West Virginia
    Businesses for Sale in Wisconsin
    Businesses for Sale in Wyoming
    Frequently
    Asked
    Questions
    • How many generic pharmaceuticals businesses for sale and investment in USA are listed on SMERGERS?
      There are 2 active and verified generic pharmaceuticals businesses for sale and investment in USA listed on SMERGERS as of 15 June 2025.
    • What level of due diligence does SMERGERS conduct on the businesses/member?

      SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more
    • How active are the business profiles listed on SMERGERS?

      We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.
    • How can I be sure about privacy and confidentiality?

      We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more
    • How can I contact a business listed on SMERGERS?

      You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more
    • Should you buy an existing business or start a business from scratch?

      Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more
    • How successful has SMERGERS been in helping its users successfully close a deal?

      SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more

      • Show more

    Dashboard
    Explore
    Settings
    Contact Us